A people-centred perspective Dr Roger Tatoud Imperial College London IRMA Global Teleconference 4 December 2009.

Slides:



Advertisements
Similar presentations
What does sexual & reproductive health have to do with clinical trials? Providing contraception & reproductive health care helps.
Advertisements

No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
What is up with Nonoxynol-9? Global Campaign for Microbicides
Session I: Characteristics Male Condoms
Hadiyah Charles, Community HIV/AIDS Mobilization Project Naina Khanna, WORLD/U.S. Positive Women’s Network HIV Research Catalyst Forum April 21, 2010.
European Network for HIV/STI Prevention and Health Promotion among Migrant Sex Workers Access to Services and Rights for sex workers.
Women at Barcelona Satellite Meeting July 7, 2002 Prevention Panel Avni Amin, Ph.D. Senior Program Associate Center for Health and Gender Equity (CHANGE)
Rectal Microbicides: The Basics Date, Location Your name, Your affiliation.
Female Condom: A Powerful Tool for Protection Journalist to Journalist Training XVI International AIDS Conference Toronto August 2006.
Session I, Slide #1 Female Condom Session I: Characteristics Female Condoms.
Dr Himani. Foams or creams that people can use in vagina or rectum during sex to prevent transmission Currently, there is no vaccine to prevent HIV. This.
Rectal Microbicides: The Basics Date, Location Your Name, Organization.
The 4 th Decade of the HIV Epidemic: Midwest Regional Response September 17, 2013 with Jim Pickett, AFC/IRMA The Bottom Line on Rectal and Vaginal Microbicide.
Jim Pickett, IRMA/AFC GMHC – January 23, 2013 The Bottom Line on Rectal Microbicide Research.
What does PrEP mean for people living with HIV? Edwin J Bernard Co-ordinator, HIV Justice Network Consultant, GNP+
Monitoring the effects of ARV treatment programmes on prevention Gabriel Mwaluko 1, Mark Urassa,2, John Changalucha,2, Ties Boerma 3 1 TANESA Project,
Midwest AIDS Training & Education Center Health Care Education & Training, Inc. HIV/AIDS Case-Finding In Family Planning Clinics.
Rectal Microbicides: The Basics October 2008, ESM Marc-André LeBlanc, GCM.
STIs/HIV/AIDS. ( 2 ) Sexually transmitted infections (STIs) are spread primarily through sexual contact and are among the most common diseases in the.
EngenderHealth/UNFPA Project – Ethiopia/Ukraine Strengthening the integration of HIV prevention in maternal health services. Increasing the capacity of.
Bheki Sithole 30 Nov Sibayeni Lodge Most at Risk Behavior Populations (MSM): Feedback, Challenges and Experiences.
Introduction to HIV New Prevention Technologies (NPTs)
Microbicides: Who, what, where, when and how Rebekah Webb Global Campaign for Microbicides © Salam Dahbor,
HIVTools Research Group The Public Health Impact of Microbicides Charlotte Watts Ph.D.
ACCESS TO AND USE OF FAMILY PLANNING BY WOMEN WITH HIV IAS, Cape Town IAS, Cape Town Revisiting Contraception and HIV Bridging Session 22 nd July 2009.
HIV Prevention and Treatment for Men who have sex with Men: Achievements and Challenges Ifeanyi Kelly Orazulike National Coordinator Sexual Minorities.
Background Study Objectives Poster No. B50 Track 2  Family planning affects women’s health and lives, and depends on a variety of socio-demographic and.
Rectal Behaviors: a global overview Shauna Stahlman & Pamina M. Gorbach UCLA Department of Epidemiology.
Office of Global Health and HIV (OGHH) Office of Overseas Programming & Training Support (OPATS) Session: Voluntary Medical Male Circumcision (VMMC)
National Working Group on Microbicides The Basics of Microbicides Amitrajit Saha PATH January 2007.
HIV and African M S M in England: A new wave of Challenge. Presented by Adebisi Alimi.
HIV Prevention : Why we need more options for women Wanjiku Kamau Consultant: International AIDS Vaccine Initiative Consultant: International Partnership.
The Microbicide Trials Network Group 3 Lindsay O. Bryant Danielle M. Campbell Alan D. Johnson Leroy Smith Jr. Kendra M. Taylor May 31, 2016.
Partnering to Promote Female-controlled HIV Prevention Methods Matthews J, Becker J, Massey C, Jacobsen J, Patel B Ibis Reproductive Health, International.
Female Condom: A Powerful Tool for Protection. Global Consultation on the Female Condom Review evidence for STI and pregnancy prevention Share program.
Rectal microbicides, where are we? Kim Mulji Naz Foundation International.
“Yes, Africa Needs Rectal Microbicides” IRMA/AVAC teleconference September 27, 2011 Jim Pickett, IRMA Chair 1 Developing an African rectal microbicide.
JOSEPH O’REILLY Deputy Chief Executive REBEKAH WEBB Policy Officer IN COLLABORATION WITH THE GLOBAL CAMPAIGN FOR MICROBICIDES IS THERE AN INVISIBLE CONDOM.
Implications of Anal Intercourse and Rectal use of Products in Vaginal Microbicide Trials Ian McGowan MD PhD FRCP.
The Joy of Tech: IRMA as a Model for Maximizing Electronic Communications to Build and Nurture an Advocacy Network May 24, 2010 Microbicides Pittsburgh.
Montreux, Switzerland, March 2007 New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications New Data on Male Circumcision and.
“AIDS has a woman’s face” -In Sub-Saharan Africa, nearly 60% of people living with HIV/AIDS are women -Teenage girls in parts of.
Eastern European Alliance for Reproductive Choice REPRODUCTIVE CHOICE FOR HIV- INFECTED WOMEN Prof. POSOKHOVA S.P. UKRAINE УКРАЇНАУКРАЇНА.
HIV/AIDS and Gender: South African Women and the Spread of Infection.
A Jo Robinson, Terrence Higgins Trust in cooperation with the Global Campaign for Microbicides Topical.
AN INTERNATIONAL MULTI-CENTRE, RANDOMISED, DOUBLE- BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF 0.5% AND 2% PRO 2000 GELS FOR.
Measuring Anal Intercourse in Vaginal Microbicide Studies/Trials
Microbicides: Addressing some key questions Lori Heise, Director Global Campaign for Microbicides.
SEXUAL BEHAVIOR HIV AND OTHER STD PREVENTION Family Life and Sexuality: Methods of Birth Control Erika Frank.
New ARV-based prevention tools how the research is happening how we need to be involved Anna Forbes, MSS Consultant, HIV and women’s health HIV Research.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
Rectal microbicides advocacy Issues, work and collaboration Kim Mulji UK rectal microbicides working group.
Looking Ahead to MTN-017 Ross D. Cranston MD, FRCP Microbicide Trials Network IRMA.
New Prevention Technologies Workshop Module 2: NPTs in context
Microbicide Acceptability: What We Know Elizabeth McGrory Population Council May 12, 2002.
“. Protects against both pregnancy AND STIs including HIV/AIDS You need condom whenever: You are unsure whether he/she or his/her partner has an STI including.
Microbicides: New Hope for Prevention of HIV and other STIs Your name here
IAS Satellite Session 25th July 2017 Daniel Were, PhD
Dual Protection = prevent pregnancy + avoid STI/HIV
New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications WHO/UNAIDS Technical Consultation on Male Circumcision and HIV.
Rectal Microbicides: Where We’re Heading
On behalf of The MTN-020/ASPIRE Study Team
HIV/AIDS in India World AIDS Day 2006 December 1
MULTIPURPOSE PREVENTION TECHNOLOGY (MPT) PRODUCT PIPELINE & THEIR POTENTIAL ACCEPTABILITY AMONG ADOLESCENT GIRLS & YOUNG WOMEN Barbara Friedland, Population.
PrEP introduction for Adolescent Girls and Young Women
Rectal Gels for PrEP Are They an Option?
A public cervix announcement: CERVICAL BARRIERS in seven minutes
José Bauermeister PhD, MPH University of Pennsylvania MTN BRWG Member
2025 AIDS targets Technical meeting on prevention
Presentation transcript:

A people-centred perspective Dr Roger Tatoud Imperial College London IRMA Global Teleconference 4 December 2009

What is a Microbicide ?

Institutional & Advocate’s definitions Global Campaign for Microbicides The word “microbicides” refers to a range of different products that share one common characteristic: the ability to PREVENT the sexual transmission of HIV and other sexually transmitted infections (STIs) when applied topically. A microbicide could be produced in many forms, including GELS, creams, suppositories, films, or as a sponge or ring that releases the active ingredient over time. Microbicides would be the most important innovation in reproductive health since the Pill. WHO Microbicides are compounds that can be applied inside the VAGINA or RECTUM to protect against sexually transmitted infections (STIs) including HIV. They can be formulated as GELS, creams, films, or suppositories. Microbicides may or may not have spermicidal activity (contraceptive effect). At present, an effective microbicide is not available. International Partnership for Microbicides Microbicides are VAGINAL products being developed to reduce the transmission of HIV during sexual intercourse. Microbicides could take the form of a GEL, film or sponge, or be contained in a VAGINAL ring that releases the active ingredient gradually. A microbicide could also be in a new formulation and use a delivery method yet to be invented. A microbicide would be a useful complement to other HIV PREVENTION measures, including safer sex education, CONDOM distribution, voluntary testing and counseling, testing and treatment of sexually transmitted infections, anti-stigma campaigns, safe blood supplies and (hopefully, one day) a vaccine. Alliance for Microbicides Development Microbicides are products being developed to reduce the transmission of HIV and other sexually transmitted infections. They are being developed in a variety of forms, such as topical GELS, creams, tablets, films, oral pills, alone or in combination with cervical barriers, rings, CONDOMs, and ancillary devices. Microbicides Trial Network Microbicides are substances designed to address the biological factors that make WOMEN more vulnerable to infection that when applied topically to the vagina could PREVENT sexual transmission of HIV. Unlike CONDOMs, microbicides represent a method that WOMEN could control themselves. Theoretically, they could be produced in many forms, including GELS, creams, suppositories, films, or as a sponge or ring that release the active ingredient over time. Some microbicides are also being developed for RECTAL use. Family Health International (FHI) Numerous microbicidal products are under development for the PREVENTION of HIV and other sexually transmitted infections (STIs). Designed to be inserted into the VAGINA and/or RECTUM prior to sexual intercourse, such products have the potential to be female-controlled, enabling WOMEN at risk of HIV to use them for protection without partner consent. Microbicides are formulated as foams, GELS, creams, impregnated sponges, suppositories, and films. Population Council VAGINAL microbicides are being developed primarily as female-initiated methods for reducing male-to-female transmission of HIV and possibly other sexually transmitted infections when used during sex. WOMEN need more options to protect themselves from infection because current PREVENTION strategies are not always feasible. While no effective microbicides yet exist, they would most likely be formulated as GELS, creams, films, or VAGINAL rings. UNAIDS Given the obstacles many WOMEN encounter when trying to negotiate the use of male CONDOMs, there is an urgent need for more PREVENTION options they can initiate themselves. Efforts are under way to develop a microbicide – a GEL or cream that can be applied topically to the VAGINA in much the same way as today’s spermicides. As a PREVENTION method that can be self-administered and might be undetectable to partners, microbicides could increase the options for WOMEN who find it difficult or impossible to persuade their spouses or other sex partners to use a CONDOM. Acceptability studies in South Africa, Uganda and Zimbabwe suggest that WOMEN who seldom or never use CONDOMS would reduce their overall risk of infection if an effective microbicide were available to them at low cost. International Rectal Microbicides Advocates (IRMA) Currently in development, a microbicide is a cream or GEL, or maybe a douche or an ENEMA, that could be used to reduce a person’s risk of HIV infection VAGINALLY or RECTALLY. RECTAL microbicides could offer both primary protection in the absence of CONDOMS and back-up protection if a CONDOM breaks or slips off during ANAL intercourse. For those unable or unwilling to use CONDOMS, RECTAL microbicides could be a safe and effective alternative means of reducing risk, especially if they were unobtrusive and/or enhanced sexual pleasure enough to motivate consistent use. Such alternatives are essential if we are to address the full spectrum of prevalent sexual practices and the basic human need for accessible, user-controlled HIV and STD PREVENTION tools.

A picture is worth 9 definitions Words that are present more than 2 times

Snapshots of Stakeholders

Condom availability and enforcement Social/cultural pressure or desire to conceive Position of women in society Disclosure & cultural practices Ability to protect herself

Snapshots of Stakeholders Condom availability or enforcement Disclosure Alternative to condom need to offer protection against pregnancy as good as condom Should protect against STIs Reliable and effective HIV prevention method

Snapshots of Stakeholders Condom availability and enforcement Condom Criminalisation “by proxy” Patron’s demand (unprotected sex/anal sex) Condom migration Economic pressure Self-controlled HIV prevention that works as well as condoms and for different sexual practices

Snapshots of Stakeholders Few issues with condom availability or enforcement Should work for AI Should protect against STIs Reliable and effective HIV prevention method as good as condom (when used) Design and usability

Snapshots of Stakeholders Condom availability, use and enforcement Condom criminalisation by proxy Position of MSM in society Should work for AI Should protect against STIs Ability to protect oneself

Efficacy? Needs, wants, advocates, users, scientists and more… Who decides? Risk Vulnerability B A C HIV Prevention Among Vulnerable Populations: The Pathfinder International Approach, 2008.

Selected Further Readings On Women and Microbicides in the US and South Africa Preventing rape and violence in South Africa: call for leadership in a new agenda for action, S.A. MRC Policy Brief November Should a moderately protective microbicide be made available in communities with high HIV incidence? Opinions of potential end-users from a rural South African community. Gafos et al., personal communication. Preferences and practices related to vaginal lubrication: Implications for microbicides acceptability and clinical testing. Braustein et al., Journal of Women’s health 2005, 14: The acceptability of an investigational vaginal microbicides, PRO 2000 gel, among women in a phase I trial, Morrow et al., Journal of Women’s health, 2003, 12: Covert use, vaginal lubrication and sexual pleasure: A qualitative study of urban U.S. Women in a vaginal microbicides clinical trial. Arch Sex behav [ahead of pub, 28 July 2009] On MSM: The global epidemic of HIV infection among men who have sex with men, Van Griesven et al., Current Opinion in HIV and AIDS 2009, 4:300–307. Testing targets: Findings from the United Kingdom Gay Men’s Sex Survey 2007, SIGMA. Mekong Erotics: Men Loving/Pleasuring/Using Men in Lao PDR, Chris Littleton, UNESCO Bangkok. On Sex Worker and new prevention strategies Sex and the new era of HIVV prevention and Care, Cheryl Overs. The role of sex worker clients in transmission of HIV in Cambodia, International Journal of STD & AIDS 2005; 16: 170– 174. Acceptability of hypothetical microbicides among women in sex establishments in rural areas in Southern China. Wang et al., Sex Transm Dis. 2008, 35: